Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

View:
Post by Calicalicali on Apr 13, 2016 7:17pm

NEWS

Even if this drug is completely shot down by the FDA Friday, can it not be sent through to be approved in Europe?  i know they run by the same guidelines as the FDA by IPN or whatever it is , but Ispen / France / 

All i keep hearing is how this management team is horrible ... So im kind of thinking they arent actively seeking that route these past few months, or even having a potential US partner that could carry out 2nd Stage 3 clinicals.  

hopefully they have because an FDA reversal is next to impossible and like others on this board have been saying, the FDA shot down this drug with a few nice words added, but the answer was pretty clear.

Dont get me wrong, im not a basher, im in heavily into this stock and would like nothing better than this stock to soar.  

Wishful thinking that the management has a positive news release coming to get some upward movement.
Comment by DamnYankees on Apr 13, 2016 8:00pm
CCC, here is what I see as possible FDA grants a path to expedited conditional approval on some limited basis - 5% and stock opens at 18 cents FDA suggests an "actionable" P3 and company provides some direction on path forward - 30% and stock opens at 10 cents  FDA Suggests " non actionable P3"  with no direction from Telesta - 30% and stock opens at 5 cents FDA ...more  
Comment by Calicalicali on Apr 13, 2016 8:15pm
Would the FDA suggest a meeting to further discuss the path forward if there were to be a 'non-actionable' p3 trial though? 
Comment by sloppytrader on Apr 13, 2016 8:20pm
Worst case scenario it gets oversold at 6 cents. 
Comment by sloppytrader on Apr 13, 2016 8:22pm
Good, and not best case scenario, goes up 300%
Comment by Calicalicali on Apr 13, 2016 8:33pm
What scenario is that? 
Comment by sloppytrader on Apr 13, 2016 8:39pm
Another phase 3 trial with a partner? I don't know...it's all speculation and I'm sitting on 200K shares. Whatever.... Damn good thing I have a good job.
Comment by sloppytrader on Apr 13, 2016 8:43pm
Average 9.5 cents/shr
Comment by sloppytrader on Apr 13, 2016 8:45pm
And a very warm "Thank you" to Budweiser!
Comment by DamnYankees on Apr 13, 2016 9:18pm
Would the company mention the term "actionable " twice if it weren't a concern. they say nothing as it is but they seem to be fond of suggesting that any new trial would have to be deemed "actionable". Reading between the lines I see a strong possibility that a move forward won't be, as do about 200,000,000 shares who split town. Maybe the FDA is being professionally ...more  
Comment by Whatamidoing1 on Apr 13, 2016 10:05pm
You do realize that when 200,000,000 split town, 200,000,000 more walk up Main Street thinking where are the retards going. Only time will tell. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities